RPL5P29

Across TCGA pan-cancer cohorts, RPL5P29 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPL5P29 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RPL5P29 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL5P29 expression acts as an unfavorable survival marker, although some lineages such as BRCA and READ show a favorable association.

BRCA, READ, and UCEC are the cancer types where RPL5P29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Median	II,III,IV	0.918	0.857	.003	53	view →
READ	OS	Median	All	0.860	0.486	.001	37	view →
UCEC	OS	Tertile	All	0.603	0.789	.006	26	view →
KIRC	DFS	Median	All	0.705	0.528	.001	24	view →
LIHC	OS	Quartile	III,IV	0.438	0.764	.003	20	view →
ACC	DFS	Tertile	All	0.242	0.800	.007	19	view →
MESO	OS	Median	III,IV	0.776	0.306	.007	18	view →
THCA	DFS	Median	All	0.957	0.910	.011	17	view →
CHOL	DFS	Tertile	All	0.798	0.103	.004	15	view →
CESC	DFS	Median	II,III,IV	0.806	0.608	.011	12	view →
GBM	DFS	Tertile	All	0.290	0.194	.028	9	view →
LUSC	DFS	Quartile	II,III,IV	0.363	0.767	.014	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RPL5P29–BRCA (DFS)

Open the BRCA breakdown →